Hive Novel Discourse

	Main Index Search Register Login Who's Online FAQ Links
	Main Index Search Register Login Who's Online FAQ Links

	1 Online, 0 Active		You are not logged in

This is a historical archiveThe forum is read-only. Private information has been removed. It is not possible to login.

	Novel Discourse

All 2 posts Subject: A new class of analgesics Please login to post Down

josef_k
(Hive Bee)
11-29-03 20:37
No 473799
A new class of analgesics

I couldn't find this in the search engine. Seems interesting. But do they show the synthesis in the full text?

ZH Liu, WQ Jin, QY Dai, XJ Chen, HP Zhang, and ZQ Chi
Opioid activity of C8813, a novel and potent opioid analgesic.
Life Sci, May 30, 2003; 73(2): 233-41.
Medline (PMID=12738037)

Abstract
Compound trans-4-(p-bromophenyl)-4-(dimethylamino)-1-(2-thiophen-2-yl-ethyl)-cyclohexanol (C8813), structurally unrelated to morphine, is a novel analgesic. The present study examined the antinociception, opioid receptor selectivity and in vitro activity of C8813. The antinociceptive activity was evaluated using mouse hot plate and acetic acid writhing tests. In mouse hot plate test, the antinociceptive ED(50) of C8813 was 11.5 microg/kg, being 591 times and 3.4 times more potent than morphine and fentanyl respectively. In mouse writhing test, the antinociceptive ED(50) of C8813 was 16.9 microg/kg, being 55 times and 2.3 times more active than morphine and fentanyl respectively. In the opioid receptor binding assay, C8813 showed high affinity for mu-opioid receptor (K(i) = 1.37 nM) and delta-opioid receptor (K(i) = 3.24 nM) but almost no affinity for kappa-opioid receptor (at 1 microM). In the bioassay, the inhibitory effect of C8813 in the guinea-pig ileum (GPI) was 16.5 times more potent than in the mouse vas deferens (MVD). The inhibitory effects of C8813 in the GPI and MVD could be antagonized by mu-opioid receptor antagonist naloxone and delta-opioid receptor antagonist ICI174,864 respectively. However, the inhibitory effect of C8813 in the rabbit vas deferens was very weak. These results indicated that C8813 was a potent analgesic and a high affinity agonist for the mu- and delta-opioid receptors.

pHarmacist
(pHantasticant)
11-29-03 20:50
No 473800
User Picture C8813

I have posted it a while ago in general discourse, but I changed my mind and deleted the post... However, here it is again...

Life Sciences 73 (2003) 233–241 (http://pharmacist8.tripod.com/C8813.pdf)

http://www.bassdrive.com/BassDrive.m3u

	https://the-hive.archive.erowid.org	the-hive@erowid.org



Powered by SubMensas v.5.7, Copyright 2020, Cacti Computer Services Limited Asia. Protected by international patents.
Links Erowid Rhodium

	All 2 posts		Subject: A new class of analgesics		Please login to post		Down


		josef_k (Hive Bee) 11-29-03 20:37 No 473799				A new class of analgesics
						I couldn't find this in the search engine. Seems interesting. But do they show the synthesis in the full text? ZH Liu, WQ Jin, QY Dai, XJ Chen, HP Zhang, and ZQ Chi Opioid activity of C8813, a novel and potent opioid analgesic. Life Sci, May 30, 2003; 73(2): 233-41. Medline (PMID=12738037) Abstract Compound trans-4-(p-bromophenyl)-4-(dimethylamino)-1-(2-thiophen-2-yl-ethyl)-cyclohexanol (C8813), structurally unrelated to morphine, is a novel analgesic. The present study examined the antinociception, opioid receptor selectivity and in vitro activity of C8813. The antinociceptive activity was evaluated using mouse hot plate and acetic acid writhing tests. In mouse hot plate test, the antinociceptive ED(50) of C8813 was 11.5 microg/kg, being 591 times and 3.4 times more potent than morphine and fentanyl respectively. In mouse writhing test, the antinociceptive ED(50) of C8813 was 16.9 microg/kg, being 55 times and 2.3 times more active than morphine and fentanyl respectively. In the opioid receptor binding assay, C8813 showed high affinity for mu-opioid receptor (K(i) = 1.37 nM) and delta-opioid receptor (K(i) = 3.24 nM) but almost no affinity for kappa-opioid receptor (at 1 microM). In the bioassay, the inhibitory effect of C8813 in the guinea-pig ileum (GPI) was 16.5 times more potent than in the mouse vas deferens (MVD). The inhibitory effects of C8813 in the GPI and MVD could be antagonized by mu-opioid receptor antagonist naloxone and delta-opioid receptor antagonist ICI174,864 respectively. However, the inhibitory effect of C8813 in the rabbit vas deferens was very weak. These results indicated that C8813 was a potent analgesic and a high affinity agonist for the mu- and delta-opioid receptors.



		pHarmacist (pHantasticant) 11-29-03 20:50 No 473800				C8813
						I have posted it a while ago in general discourse, but I changed my mind and deleted the post... However, here it is again... Life Sciences 73 (2003) 233–241 (http://pharmacist8.tripod.com/C8813.pdf) http://www.bassdrive.com/BassDrive.m3u

All 2 posts	End of thread	Top